In vivo and in vitro Evaluation of Cytokine Expression Profiles During Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection

References

• Al-Qahtani AA, Lyroni K, Aznaourova M, et al. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. Oncotarget. 2017;8(6):9053–9066. doi:10.18632/oncotarget.14754
   PubMedGoogle Scholar
• Mubarak A, Alturaiki W, Hemida MG. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): infection, Immunological Response, and Vaccine Development. J Immunol Res. 2019;2019:6491738. doi:10.1155/2019/6491738
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–1820. doi:10.1056/NEJMoa1211721
   PubMed Web of Science ®Google Scholar
• Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675–687. doi:10.1038/nri888
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Geng H, et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 2013;4(12):951–961. doi:10.1007/s13238-013-3096-8
   PubMed Web of Science ®Google Scholar
• Alexopoulou L. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 2001;413(6857):732–738.
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol. 2008;20(1):17–22. doi:10.1016/j.coi.2008.01.002
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol. 2004;5(7):730–737. doi:10.1038/ni1087
   PubMed Web of Science ®Google Scholar
• Mahallawi WH, Khabour OF, Zhang Q, et al. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018;104:8–13. doi:10.1016/j.cyto.2018.01.025
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Fehr AR, Zheng J, et al. IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019;129(9):3625–3639. doi:10.1172/JCI126363
   PubMed Web of Science ®Google Scholar
• Lui PY, Wong L-YR, Fung C-L, et al. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3. Emerg Microbes Infect. 2016;5(1):e39. doi:10.1038/emi.2016.33
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Geng H, et al. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell. 2013;4(12):951–961.
   PubMed Web of Science ®Google Scholar
• Siu K-L, Yeung ML, Kok K-H, et al. Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response. J Virol. 2014;88(9):4866–4876. doi:10.1128/JVI.03649-13
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
   PubMed Web of Science ®Google Scholar
• Scheuplein VA, Seifried J, Malczyk AH, et al. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol. 2015;89(7):3859–3869. doi:10.1128/JVI.03607-14
   PubMed Web of Science ®Google Scholar
• Li J, Liu Y, Zhang X. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J Virol. 2010;84(13):6472–6482. doi:10.1128/JVI.00016-10
   PubMed Web of Science ®Google Scholar
• Birmachu W, Gleason RM, Bulbulian BJ, et al. Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists. BMC Immunol. 2007;8(1):26. doi:10.1186/1471-2172-8-26
   PubMedGoogle Scholar
• Coccia EM, Severa M, Giacomini E, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol. 2004;34(3):796–805. doi:10.1002/eji.200324610
   PubMed Web of Science ®Google Scholar
• Alosaimi B, Hamed ME, Naeem A, et al. MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract. Cytokine. 2020;126:154895. doi:10.1016/j.cyto.2019.154895
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Zhan Y, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72(8):4410–4415. doi:10.1128/IAI.72.8.4410-4415.2004
   PubMed Web of Science ®Google Scholar
• Wong CK, Lam CWK, Wu AKL, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136(1):95–103. doi:10.1111/j.1365-2249.2004.02415.x
   PubMed Web of Science ®Google Scholar
• Mella C, Suarez-Arrabal MC, Lopez S, et al. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2013;207(4):564–573. doi:10.1093/infdis/jis721
   PubMed Web of Science ®Google Scholar
• Alhetheel A, Albarrag A, Shakoor Z, et al. Assessment of Th1/Th2 cytokines among patients with Middle East respiratory syndrome coronavirus infection. Int Immunol. 2020;32(12):799–804. doi:10.1093/intimm/dxaa047
   PubMed Web of Science ®Google Scholar
• Sabat R. IL-10 family of cytokines. Cytokine Growth Factor Rev. 2010;21(5):315–324. doi:10.1016/j.cytogfr.2010.11.001
   PubMed Web of Science ®Google Scholar
• Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7(6):439–450. doi:10.1038/nrmicro2147
   PubMed Web of Science ®Google Scholar
• Faure E, Poissy J, Goffard A, et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? PLoS One. 2014;9(2):e88716. doi:10.1371/journal.pone.0088716
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhou J, Zhang B, et al. Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog. 2013;9(6):e1003410. doi:10.1371/journal.ppat.1003410
   PubMed Web of Science ®Google Scholar
• Josset L, Menachery VD, Gralinski LE, et al. Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. mBio. 2013;4(3):e00165–13. doi:10.1128/mBio.00165-13
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7(9):937–945. doi:10.1038/ni1376
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Silver JS, Laurence A, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol. 2007;8(12):1363–1371. doi:10.1038/ni1537
   PubMed Web of Science ®Google Scholar
• Povroznik JM, Robinson CM. IL-27 regulation of innate immunity and control of microbial growth. Future Sci OA. 2020;6(7):FSO588. doi:10.2144/fsoa-2020-0032
   PubMed Web of Science ®Google Scholar
• Liu FDM, Kenngott EE, Schröter MF, et al. Timed action of IL-27 protects from immunopathology while preserving defense in influenza. PLoS Pathog. 2014;10(5):e1004110. doi:10.1371/journal.ppat.1004110
   PubMed Web of Science ®Google Scholar
• Yang L. Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection. Virol J. 2019;16(1):48. doi:10.1186/s12985-019-1158-0
   PubMedGoogle Scholar
• Shao X, Ma J, Jia S, et al. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection. Front Cell Infect Microbiol. 2017;7:472. doi:10.3389/fcimb.2017.00472
   PubMed Web of Science ®Google Scholar